Inclusion formation in Huntington's disease R6/2 mouse muscle cultures
- PMID: 12969246
- DOI: 10.1046/j.1471-4159.2003.02009.x
Inclusion formation in Huntington's disease R6/2 mouse muscle cultures
Abstract
Huntington's disease (HD) is an autosomal dominant disorder caused by an expansion in the number of glutamine repeats in the N-terminal region of the huntingtin protein. Nuclear and cytoplasmic aggregates of the N-terminal portion of huntingtin have been found in the brains of HD patients and the brains and non-neuronal tissues of the R6/2 HD transgenic mouse. We have cultured myoblasts and myotubes from transgenic R6/2 mice and littermate controls to investigate the formation of these inclusions in post mitotic cells. Huntingtin immunoreactivity was intense in differentiating, desmin positive myoblasts and myotubes from both control and R6/2 mice suggesting that it may play a role in myotube differentiation. Following differentiation huntingtin and ubiquitin positive aggregates were observed in R6/2 but not control cultures. After 3 weeks in differentiation medium cytoplasmic huntingtin and ubiquitin immunoreactive aggregates were observed in non-myotube cells, while nuclear huntingtin aggregates were seen in a proportion of myotubes after 6 weeks. Growth in the absence of serum resulted in a marked increase in the number of R6/2 myotubes containing nuclear inclusions after 6 weeks demonstrating that environmental factors influenced huntingtin aggregate formation in these cells. Consequently, cultured myotubes from R6/2 mice may be a useful post mitotic cell culture model to study both the biochemical consequences of huntingtin aggregates and the factors that may influence aggregate formation.
Similar articles
-
Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects.Cell Death Differ. 2006 Dec;13(12):2068-78. doi: 10.1038/sj.cdd.4401967. Epub 2006 May 26. Cell Death Differ. 2006. PMID: 16729030
-
Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.PLoS One. 2009 Nov 30;4(11):e8025. doi: 10.1371/journal.pone.0008025. PLoS One. 2009. PMID: 19956633 Free PMC article.
-
Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.Neurobiol Dis. 2019 Jan;121:214-229. doi: 10.1016/j.nbd.2018.09.025. Epub 2018 Oct 5. Neurobiol Dis. 2019. PMID: 30292559 Free PMC article.
-
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1047-55. doi: 10.1098/rstb.1999.0457. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434304 Free PMC article. Review.
-
Transgenic models of Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.
Cited by
-
Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.Neurobiol Dis. 2007 Feb;25(2):297-308. doi: 10.1016/j.nbd.2006.09.016. Epub 2006 Nov 27. Neurobiol Dis. 2007. PMID: 17126554 Free PMC article.
-
In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease.Pharmaceutics. 2025 May 30;17(6):726. doi: 10.3390/pharmaceutics17060726. Pharmaceutics. 2025. PMID: 40574039 Free PMC article.
-
Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse.Front Mol Neurosci. 2024 Jan 3;16:1287510. doi: 10.3389/fnmol.2023.1287510. eCollection 2023. Front Mol Neurosci. 2024. PMID: 38235149 Free PMC article.
-
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease.Sci Rep. 2017 Oct 24;7(1):13896. doi: 10.1038/s41598-017-13713-5. Sci Rep. 2017. PMID: 29066728 Free PMC article.
-
Impaired PGC-1alpha function in muscle in Huntington's disease.Hum Mol Genet. 2009 Aug 15;18(16):3048-65. doi: 10.1093/hmg/ddp243. Epub 2009 May 21. Hum Mol Genet. 2009. PMID: 19460884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical